or
forgot password

    • cancer clinical trials in clarksville, TN

    • A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Lymphoma, Follicular
    Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Kidney Cancer
    Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer, Breast Neoplasms
    High-dose Bevacizumab in Advanced Renal Carcinoma Patients
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Renal Cancer, Kidney Cancer
    Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Chronic Lymphocytic Leukemia
    Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non-Small Cell Lung Cancer
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non-Small Cell Lung Cancer
    Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Mantle Cell Lymphoma
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Renal Cell Carcinoma
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Carcinoma
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Glioblastoma Multiforme
    Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Breast Cancer
    Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Advanced Renal Cell Carcinoma
    Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Unknown Primary Cancer
    Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    Trial of Poor Performance Status Patients (ToPPS)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non Small Cell Lung Cancer
    Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non Small Cell Lung Cancer
    Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Breast Cancer
    SCRI Tissue Testing Registry
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Melanoma, Myelodysplastic Syndrome, Multiple Myeloma, Lymphoma
    Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Melanoma
    Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Breast Cancer
    Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non-Small-Cell Lung Cancer
    Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Extensive-Stage Small Cell Lung Cancer
    Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Adenocarcinoma of the Lung
    BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Renal Cell Carcinoma
    Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Leukemia
    Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Multiple Myeloma, Waldenstrom Macroglobulinemia
    Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Colorectal Cancer
    Epidermal Growth Factor Receptor-tested Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non Small Cell Lung Cancer
    Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Chronic Phase Chronic Myeloid Leukemia
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Squamous Cell Non-small Cell Lung Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non-Squamous Cell Non-small Cell Lung Cancer
    Phase Ib Study of IPI-145 in Combination With Bendamustine, Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, T-cell Lymphoma
    A Retrospective Cohort Study of Infusion Reactions Due to Vectibix
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Infusion Reaction
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Clarksville Regional Hematology/Oncology
    Clarksville, Tennessee 37043
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Carcinoma, Non-Small-Cell Lung
    Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Lung Cancer
    Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Prostate Cancer
    Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Head and Neck Cancer
    Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Multiple Myeloma
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Neoplasms, Unknown Primary
    Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Neoplasms, Unknown Primary
    Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Carcinoma, Small Cell, Lung Cancer
    Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Small Cell Lung Cancer, Carcinoma, Small Cell